13G Filing: BML Investment Partners, L.P. and Inotek Pharmaceuticals Corp (ITEK)

Page 3 of 4 – SEC Filing

CUSIP
No. 
45780V102    
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Braden M Leonard
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)

(a)
o
(b)
x
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF SHARES
BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH:
5 SOLE VOTING POWER
30,000
6 SHARED VOTING POWER
1,295,395
7 SOLE DISPOSITIVE POWER
30,000
8 SHARED DISPOSITIVE POWER
1,295,395
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
1,325,395
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
o
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.9%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN

FOOTNOTES

Follow Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)